DL and D Sotalol Decrease Defibrillation Energy Requirements
Authors:
- 1 September 1989
- journal article
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 12 (9) , 1522-1529
Abstract
We examined the acute effects of intravenous DL and D sotalol on the energy requirements for internaJ defibrillation (DF) in 44 dogs anesthetized with pentobarbital (n = 18), enflurane (n = B), and fentanyl (n = 18). Multiple shocks of varying energies were applied through left and right ventricular epicardial patch electrodes to relate delivered energy to percent success in DF. The energies required for 50% success in DF (E) were estimated by logistic regression. DL or D sotalol was administered in a loading (4 mg/kg over 10 min) and maintenance (1.5 mg/kg/hr) infusion and the energy—success curve was again measured 30 minutes after drug administralion. The effect of DL and D sotalol on E50 was compared to controls given saline. Both DL and D sotalol significantly lowered E50 by 16%± 14% (P < 0.05) and 24.5%± 8.2% (P < 0.05), respectively, in fentanyl anesthetized animals; this was accompanied by a 22%± 8% (P < 0.05) and 16%± 5% (P < 0.01) increase in ventricular elective refractory period (VERP), respectively. In pentobarbital anesthetized dogs, DL and D sotalol decreased E50 by 16%± 27% (P = ns) and 11%± 16% (P < 0.05), respectively, and were associated with a 23%± 5% (P < 0.01) and 12 ± 4% (P < 0.05) prolongation of VERP. DL and D sotalol decrease defibrillation energy requirements, possibly as a result of their Class III antiarrhythmic drug action.Keywords
This publication has 25 references indexed in Scilit:
- Effects of acute intravenous and chronic oral amiodarone on defibrillation energy requirementsAmerican Heart Journal, 1987
- Effects of encainide and its metabolites on energy requirements for defibrillation.Circulation, 1986
- Adrenergically mediated variations in the energy required to defibrillate the heart: observations in closed-chest, nonanesthetized dogs.Circulation, 1986
- Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias.Circulation, 1985
- Coronary thrombolysis in dogs with intravenously administered human pro-urokinase.Circulation, 1985
- Prolongation of the human cardiac monophasic action potential by sotalolThe American Journal of Cardiology, 1982
- Elevation of ventricular defibrillation threshold in dogs by antiarrhythmic drugsAmerican Heart Journal, 1979
- A third class of anti‐arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474British Journal of Pharmacology, 1970
- Electrophysiological and Beta-Receptor Blocking Effects of MJ 1999 on Dog and Rabbit Cardiac TissueCirculation Research, 1970
- The effect of quinidine on electrical energy required for ventricular defibrillationAmerican Heart Journal, 1966